These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 16198834)
1. Evolving concepts of dyslipidemia, atherosclerosis, and cardiovascular disease: the Louis F. Bishop Lecture. Gotto AM J Am Coll Cardiol; 2005 Oct; 46(7):1219-24. PubMed ID: 16198834 [No Abstract] [Full Text] [Related]
2. [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary]. ; Grundy SM; Arai H; Barter P; Bersot TP; Betteridge DJ; Carmena R; Cuevas A; Davidson MH; Genest J; Kesäniemi YA; Sadikot S; Santos RD; Susekov A; Sy R; Tokgozoglu L; Watts GF; Zhao D; Clin Investig Arterioscler; 2014; 26(1):33-7. PubMed ID: 24169377 [No Abstract] [Full Text] [Related]
4. Current ways of treating dyslipidemias to prevent atherosclerosis. Angelico F; Baratta F; Del Ben M Ther Apher Dial; 2013 Apr; 17(2):125-9. PubMed ID: 23551668 [No Abstract] [Full Text] [Related]
8. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy. Fazio S Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268 [TBL] [Abstract][Full Text] [Related]
9. [Prevention and treatment of atherosclerosis and cardiovascular diseases]. Knobler H; Bitzur R; Gavish D; Rubinstein A; Henkin Y; Chajek-Shaul T; Harats D Harefuah; 2012 May; 151(5):281-8, 319, 318. PubMed ID: 22844732 [TBL] [Abstract][Full Text] [Related]
10. Traditional cardiovascular risk factors in primary Sjögren's syndrome--role of dyslipidaemia. Gerli R; Bartoloni Bocci E; Vaudo G; Marchesi S; Vitali C; Shoenfeld Y Rheumatology (Oxford); 2006 Dec; 45(12):1580-1; author reply 1581-2. PubMed ID: 17043043 [No Abstract] [Full Text] [Related]
12. Associations of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study. Juonala M; Viikari JS; Rönnemaa T; Marniemi J; Jula A; Loo BM; Raitakari OT Arterioscler Thromb Vasc Biol; 2008 May; 28(5):1012-7. PubMed ID: 18309111 [TBL] [Abstract][Full Text] [Related]
13. Atherogenic dyslipidemia and oxidative stress: a new look. Rizzo M; Kotur-Stevuljevic J; Berneis K; Spinas G; Rini GB; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Vekic J Transl Res; 2009 May; 153(5):217-23. PubMed ID: 19375682 [TBL] [Abstract][Full Text] [Related]
14. The use of lipid-lowering drug therapy in children and adolescents. Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879 [TBL] [Abstract][Full Text] [Related]
15. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management. Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582 [TBL] [Abstract][Full Text] [Related]
16. [Diabetic dyslipoproteinemia: beyond LDL]. Merkel M Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932 [TBL] [Abstract][Full Text] [Related]
19. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548 [TBL] [Abstract][Full Text] [Related]